Bacariza, Jessa May .
HRN: 26-54-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2025
CEFUROXIME 1.5GM (VIAL)
01/28/2025
01/29/2025
IV
1.5g
Q8h X 4 Doses
Sp NSVD With RMLE; UTI
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes